Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.

Vanassche, T; Engelen, M M; Van Thillo, Q; Wauters, J; Gunst, J; Wouters, C; Vandenbriele, C; Rex, S; Liesenborghs, L; Wilmer, A; Meersseman, P; Van den Berghe, G; Dauwe, D; Verbeke, G; Thomeer, M; Fivez, T; Mesotten, D; Ruttens, D; Heytens, L; Dapper, I; Tuyls, S; De Tavernier, B; Verhamme, P

Vanassche, T; Engelen, M M; Van Thillo, Q; Wauters, J; Gunst, J; Wouters, C; Vandenbriele, C; Rex, S; Liesenborghs, L; Wilmer, A; Meersseman, P; Van den Berghe, G; Dauwe, D; Verbeke, G; Thomeer, M; Fivez, T; Mesotten, D; Ruttens, D; Heytens, L; Dapper, I; Tuyls, S; De Tavernier, B; Verhamme, P.

Vanassche T; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.
Engelen MM; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.
Van Thillo Q; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Wauters J; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Gunst J; Center for Cancer Biology, VIB, Leuven, Belgium.
Wouters C; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Vandenbriele C; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Rex S; Pediatric Rheumatology, University Hospitals Leuven, Leuven, Belgium.
Liesenborghs L; Laboratory of Adaptive Immunology & Immunobiology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Wilmer A; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Meersseman P; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Van den Berghe G; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Dauwe D; Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.
Verbeke G; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Thomeer M; REGA Institute, KU Leuven, Leuven, Belgium.
Fivez T; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Mesotten D; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Ruttens D; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Heytens L; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Dapper I; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), KU Leuven, Leuven, and Hasselt University (UHasselt), Hasselt, Belgium.
Tuyls S; Department of Respiratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.
De Tavernier B; Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Verhamme P; Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Trials ; 21(1): 1033, 2020 Dec 29.

Article in English | MEDLINE | ID: covidwho-1035066

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2020 Document Type: Article Affiliation country: S13063-020-04991-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google